Potential public health hazards of biosynthetic milk hormones

The use of biosynthetic milk hormones raises fundamental ethical, social, and economic considerations, including the continued viability of the small family dairy farm and adverse veterinary effects. The past and expanding use of synthetic bovine growth hormone manufactured by the Agricultural Chemicals Division of Elanco (Eli Lilly and Co.) in conjunction with Dow Chemical Co. and Upjohn Co., and its methionyl analog, manufactured by American Cyanamid Co. and Monsanto Co., also poses significant potential public health hazards which have not so far been investigated. These concerns are exacerbated by the domination of synthetic hormone research by industry and its indentured academics, by failure of the industries concerned to disclose their unpublished data, by their manipulation of published data, and by refusal to label milk and meat from cows treated with biosynthetic hormones, and by denial of consumers' rights to know. These concerns are further exacerbated by the abdication of regulatory responsibility by the Food and Drug Administration and U.S. Department of Agriculture.